Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex32131d3bb.htm |
| EX-31.1 - EX-31.1 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex31181bbd4.htm |
| EX-10.9 - EX-10.9 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex10947ec03.htm |
| EX-10.21 - EX-10.21 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex102155e74.htm |
| EX-10.20 - EX-10.20 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex10200976d.htm |
| EX-10.18 - EX-10.18 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex10180e577.htm |
| EX-10.17 - EX-10.17 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex101750a3d.htm |
| EX-10.15 - EX-10.15 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex10157b9f3.htm |
| EX-10.14 - EX-10.14 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex1014eda14.htm |
| EX-10.10 - EX-10.10 - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231ex10103c720.htm |
| 10-K - 10-K - ALPINE IMMUNE SCIENCES, INC. | nvls-20161231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1. |
Registration Statement (Form S-8 No. 333-205220) pertaining to the 2012 Stock Incentive Plan, 2015 Equity Incentive Plan, and Employee Stock Purchase Plan of Nivalis Therapeutics, Inc., |
|
2. |
Registration Statement (Form S-8 No. 333-211197) pertaining to the Employment Inducement Awards, granted by Nivalis Therapeutics, Inc., and |
|
3. |
Registration Statement (Form S-3 No. 333-212404) of Nivalis Therapeutics, Inc. |
of our report dated February 13, 2017, with respect to the financial statements of Nivalis Therapeutics, Inc., included in this Annual Report (Form 10-K) of Nivalis Therapeutics, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young, LLP
Denver, Colorado
February 13, 2017